• / Free eNewsletters & Magazine
  • / My Account
Home>After Hours Trading

After Hours Trading

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. FDA Approves Amgen's Biosimilar Version of Humira

    FDA Approves Amgen's Biosimilar Version of Humira

  2. FDA Approves Amgen's Biosimilar Version of Humira -- Update

    FDA Approves Amgen's Biosimilar Version of Humira -- Update

  3. FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update

    FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update

  4. Novatel Wireless to Sell Mobile-Broadband Unit, Restructure

    Novatel Wireless to Sell Mobile-Broadband Unit, Restructure

  5. Gilead Sciences Halts Test of Bowel Disease Treatment

    Gilead Sciences Halts Test of Bowel Disease Treatment

  6. Microsoft Plans $40 Billion Stock Buyback and Raises Dividend

    Microsoft Plans $40 Billion Stock Buyback and Raises Dividend

  7. Adobe Results Boosted by Subscription Sales

    Adobe Results Boosted by Subscription Sales

  8. Microsoft Plans $40 Billion Stock Buyback and Raises Dividend -- Update

    Microsoft Plans $40 Billion Stock Buyback and Raises Dividend -- Update

  9. Lennar, KB Home Profits Top Estimates Amid Housing Recovery--2nd Update

    Lennar, KB Home Profits Top Estimates Amid Housing Recovery--2nd Update

  10. FedEx Lifts Outlook as It Integrates TNT Express -- 3rd Update

    FedEx Lifts Outlook as It Integrates TNT Express -- 3rd Update

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.